Patients’ characteristics at diagnosis
| Characteristics . | Value . |
|---|---|
| Number of patients | 19 |
| Sex | |
| Male | 11 |
| Female | 8 |
| Disease severity at diagnosis | |
| VSAA | 5 |
| SAA | 8 |
| NSAA | 6 |
| PNH clone | |
| Yes | 11 |
| No | 7 |
| Unknown | 1 |
| Size of PNH clone, % | |
| Red cells | 0.02 to 0.15 |
| Granulocytes | 0.003 to 29.3 |
| Monocytes | 0.4 to 25.7 |
| Etiology | |
| Idiopathic | 19 |
| Treatment | |
| IST | 12 |
| Eltrombopag | 2 |
| IST + Eltrombopag | 1 |
| Allogeneic stem cell transplantation | 1 |
| No treatment | 3 |
| Response to IST treatment | |
| CR | 2 |
| PR | 6 |
| NR | 4 |
| Characteristics . | Value . |
|---|---|
| Number of patients | 19 |
| Sex | |
| Male | 11 |
| Female | 8 |
| Disease severity at diagnosis | |
| VSAA | 5 |
| SAA | 8 |
| NSAA | 6 |
| PNH clone | |
| Yes | 11 |
| No | 7 |
| Unknown | 1 |
| Size of PNH clone, % | |
| Red cells | 0.02 to 0.15 |
| Granulocytes | 0.003 to 29.3 |
| Monocytes | 0.4 to 25.7 |
| Etiology | |
| Idiopathic | 19 |
| Treatment | |
| IST | 12 |
| Eltrombopag | 2 |
| IST + Eltrombopag | 1 |
| Allogeneic stem cell transplantation | 1 |
| No treatment | 3 |
| Response to IST treatment | |
| CR | 2 |
| PR | 6 |
| NR | 4 |
CR, complete response; NR, no response; NSAA, nonsevere aplastic anemia; PNH, paroxysmal nocturnal hemoglobinuria; PR, partial response; SAA, severe aplastic anemia; VSAA, very severe aplastic anemia.